KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) FCF Margin (2016 - 2025)

Edwards Lifesciences has reported FCF Margin over the past 17 years, most recently at 22.52% for Q4 2025.

  • Quarterly results put FCF Margin at 22.52% for Q4 2025, up 3532.0% from a year ago — trailing twelve months through Dec 2025 was 22.0% (up 1667.0% YoY), and the annual figure for FY2025 was 22.0%, up 1667.0%.
  • FCF Margin for Q4 2025 was 22.52% at Edwards Lifesciences, down from 33.24% in the prior quarter.
  • Over the last five years, FCF Margin for EW hit a ceiling of 49.76% in Q4 2022 and a floor of 12.79% in Q4 2024.
  • Median FCF Margin over the past 5 years was 20.79% (2024), compared with a mean of 18.67%.
  • Biggest five-year swings in FCF Margin: tumbled -4594bps in 2023 and later skyrocketed 3532bps in 2025.
  • Edwards Lifesciences' FCF Margin stood at 21.34% in 2021, then soared by 133bps to 49.76% in 2022, then tumbled by -92bps to 3.81% in 2023, then tumbled by -435bps to 12.79% in 2024, then soared by 276bps to 22.52% in 2025.
  • The last three reported values for FCF Margin were 22.52% (Q4 2025), 33.24% (Q3 2025), and 15.72% (Q2 2025) per Business Quant data.